ImageneBio, Inc. — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ikena Oncology, Inc. (IKNA)
CIK: 0001835579
Period of Report: 2021-04-15

Reporting Person: Koehler Maria (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Stock Option (Right to Buy)	$18.45	A	26838	Acquired	2031-04-15	Common Stock (26838)	Direct

Footnotes

F1: This option shall vest and become exercisable in 36 equal monthly installments beginning on April 15, 2021.